Search Results for "Investment Framework Aids"

09:59 EST 16th January 2017 | BioPortfolio

Matching Channels

Hyponatremia in AIDS

Hearing aids

AIDS Cholangiopathy

AIDS cholangiopathy is biliary obstruction secondary to biliary tract strictures caused by various opportunistic infections. Before the advent of highly active antiretroviral therapy, cholangiopat...


Maryland, the US state on the mid-Atlantic coast, is hub of biotechnology institutions and companies. In 2005/2006 is was the 2nd best area globally for initiatives aimed at drawing and retaining bi...


India, in the Asian subcontinent is the world’s fourth largest producer of pharmaceuticals, and is thought as one of the most promising biotech markets in the world. Several important steps ...

Matching News

BRIEF-Shanghai Fosun Pharmaceutical Group signs investment cooperation framework agreement with The Second Hospital University of South China

* Says it signed an investment cooperation framework agreement with The Second Hospital University of South China

BRIEF-Jiangsu Bicon Pharma plans new material project with investment of 1.5 bln yuan

* Says it signs framework agreement on new material project with investment of 1.5 billion yuan ($224.95 million)

Is Gilead Infected With The Big Pharma Virus?

This article provides a review of the ViiV pipeline and some thoughts about Gilead in relation to that, and about Gilead overall as an investment choice. Has Gilead moved so far from R&D and produ...

Global Response to Fight AIDS Urgently Needed This World AIDS Day

In recognition of World AIDS Day, held annually on Dec. 1 each year since 1988, the Forum of International Respiratory Societies (FIRS) is calling on governments, health advocates and non-government o...

Flashback: Radical AIDS Activist Group ACT UP

The AIDS Coalition to Unleash Power, better known as ACT UP, was formed in 1987 to protest the government's slow response to the AIDS crisis. In

World AIDS Day 2016: A decade of scientific innovation

On World AIDS Day, we are reminded of the significant advances that have been made – many of which occurred over the past decade – to help transform HIV/AIDS from a once acutely fatal ...

HIV/AIDS in 2016 and Beyond

This Medical News feature discusses the progress and challenges in HIV/AIDS treatement and research highlighted by the 2016 International AIDS conference in Durban, South Africa.

BRIEF-Changsheng Bio Technology signs agreement on biopharma project with investment of 2 bln yuan

* Says it signs framework agreement on biopharma project with investment of 2.0 billion yuan ($295.06 million)

Matching PubMed Articles

Optimizing HIV/AIDS resources in Armenia: increasing ART investment and examining HIV programmes for seasonal migrant labourers.

HIV prevalence is declining in key populations in Armenia including in people who inject drugs (PWID), men who have sex with men, prison inmates, and female sex workers (FSWs); however, prevalence is ...

Non-AIDS Defining Cancer Mortality: Emerging Patterns in the Late HAART Era.

Non-AIDS defining cancers (non-ADCs) have become the leading non-AIDS-related cause of death among people with HIV/AIDS. We aimed to quantify the excess risk of cancer-related deaths among Italian peo...

Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: Investment needs, population health gains, and cost-effectiveness.

We estimated the investment need, population health gains, and cost-effectiveness of different policy options for scaling-up prevention and treatment of HIV in the 10 countries that currently comprise...

Understanding the relationship between safety investment and safety performance of construction projects through agent-based modeling.

The construction industry in Hong Kong increased its safety investment by 300% in the past two decades; however, its accident rate has plateaued to around 50% for one decade. Against this backdrop, re...

What Is Required to End the AIDS Epidemic as a Public Health Threat by 2030? The Cost and Impact of the Fast-Track Approach.

In 2011 a new Investment Framework was proposed that described how the scale-up of key HIV interventions could dramatically reduce new HIV infections and AIDS-related deaths in low and middle income c...

Search Whole site using Google

Quick Search
Advertisement Advertisement